SS
IMCR icon

Steve Schonfeld’s Immunocore IMCR Stock Holding History

Steve Schonfeld’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,648
Closed -$960K – 2433
2025
Q4 		$960K Buy
27,648
+7,726
+39% +$273K ﹤0.01% 1135
2025
Q3 		$724K Buy
+19,922
New +$677K ﹤0.01% 1528
2024
Q3 		– Sell
-30,936
Closed -$1.05M – 2211
2024
Q2 		$1.05M Buy
+30,936
New +$1.58M 0.01% 1188
2022
Q3 		– Sell
-25,200
Closed -$940K – 3065
2022
Q2 		$940K Buy
+25,200
New +$819K 0.01% 1058

Other funds holding IMCR

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Steve Schonfeld's IMCR Position: Q1 2026 in Review

Steve Schonfeld sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 27,648 shares — an estimated $960K sold.

Steve Schonfeld first reported a position in IMCR in Q2 2022 and held it in 4 quarters. The position peaked at $1.05M in Q2 2024. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Steve Schonfeld reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
  • Steve Schonfeld sold 27,648 Immunocore shares in Q1 2026, an estimated $960K.
  • Steve Schonfeld first reported a position in Immunocore in Q2 2022 and held it in 4 quarters.
  • Steve Schonfeld's Immunocore position peaked at $1.05M in Q2 2024.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.